Table 3. External validation measures of prognostic models for LACC.
| Characteristic | Model | Outcome/Total | Time (yr) | AUROC | Calibration intercept | Calibration slope | R2N (%) | Brier score |
|---|---|---|---|---|---|---|---|---|
| OS | Rose et al. [20] | 80/216 | 5 | 0.66 (0.59, 0.74) | −0.72 (−1.04, −0.43) | 0.82 (0.43, 1.25) | 10.40 (3.01, 20.71) | 0.21 (0.19, 0.23) |
| Kidd et al. [19] | 9/92 | 1 | 0.67 (0.48, 0.86) | −0.17 (−2.95, 2.32) | 1.01 (−0.30, 2.32) | 5.24 (0.00, 16.82) | 0.09 (0.04, 0.14) | |
| Kidd et al. [19] | 21/53 | 3 | 0.69 (0.54, 0.84) | 0.23 (−0.81, 1.38) | 0.88 (−0.30, 2.17) | 5.32 (0.00, 30.54) | 0.23 (0.20, 0.28) | |
| CSS | Shim et al. [14] | 69/240 | 3 | 0.52 (0.45, 0.60) | −0.89 (−1.44, −0.41) | 0.01 (−0.36, 0.37) | 0.01 (0.00, 0.30) | 0.20 (0.18, 0.23) |
| Shim et al. [14] | 76/213 | 5 | 0.55 (0.47, 0.63) | −0.49 (−0.86, −0.12) | 0.13 (−0.18, 0.53) | 0.39 (0.00, 5.11) | 0.23 (0.21, 0.24) | |
| Tseng et al. [15] | 75/211 | 5 | 0.64 (0.57, 0.72) | −1.30 (−1.94, −0.83) | 0.98 (0.51, 1.66) | 8.59 (1.78, 18.42) | 0.21 (0.19, 0.23) | |
| Kidd et al. [19] | 9/92 | 1 | 0.60 (0.38, 0.82) | −1.37 (−3.66, 0.77) | 0.38 (−0.55, 1.42) | 1.44 (0.00, 17.87) | 0.09 (0.04, 0.14) | |
| Kidd et al. [19] | 20/52 | 3 | 0.58 (0.41, 0.75) | −0.04 (−1.21, 1.14) | 0.31 (−0.43, 1.07) | 1.83 (0.00, 24.87) | 0.23 (0.17, 0.25) | |
| DFS | Rose et al. [20] | 87/264 | 2 | 0.70 (0.63, 0.76) | −0.25 (−0.59, 0.09) | 1.19 (0.75, 1.71) | 14.42 (6.02, 25.17) | 0.20 (0.17, 0.22) |
| Kidd et al. [19] | 26/93 | 1 | 0.64 (0.51, 0.76) | −0.24 (−1.24, 0.82) | 0.57 (−0.12, 1.33) | 4.17 (0.00, 18.27) | 0.20 (0.15, 0.23) | |
| Kidd et al. [19] | 32/58 | 3 | 0.60 (0.45, 0.73) | 0.32 (−0.27, 1.34) | 0.26 (−0.41, 1.45) | 1.23 (0.00, 17.73) | 0.24 (0.20, 0.25) | |
| Liang et al. [16] | 99/236 | 4 | 0.64 (0.59, 0.70) | - | - | - | - | |
| Rd | Kang et al. [17] | 38/163 | 5 | 0.67 (0.58, 0.77) | 0.25 (−0.67, 1.39) | 1.00 (0.34, 1.73) | 7.77 (1.03, 19.64) | 0.17 (0.13, 0.20) |
| Kang et al. [17] | 38/163 | 5 | 0.63 (0.54, 0.72) | - | - | - | - | |
| Rp | Liang et al. [16] | 18/155 | 4 | 0.58 (0.46, 0.69) | - | - | - | - |
The cells show the estimate value and 95% CIs bootstrap estimate value using normal approximation.
AUROC, area under the receiver operating characteristic curve; CI, confidence interval; CSS, cause-specific survival; DFS, disease-free survival; LACC, locally advanced cervical cancer; OS, overall survival; Rd, distant recurrence; Rp, para-aortic recurrence.